Dexmedetomidine combined with propofol improves hemodynamic stability and recovery in elderly patients undergoing thoracoscopic lung cancer resection

The combination of dexmedetomidine and propofol enhances intraoperative hemodynamic stability, accelerates recovery, reduces perioperative stress and inflammation, and lowers the incidence of adverse events in elderly patients undergoing thoracoscopic lung cancer resection. These results support its clinical value, particularly in high-risk subpopulations. Further studies are needed to refine dosing strategies and optimize safety.